Diagnostic Performance of GeneChip for the Rapid Detection of Drug-Resistant Tuberculosis in Different Subgroups of Patients

References

• WHO. Global Tuberculosis Report 2020. Geneva: World Health Organization; 2020.
   Google Scholar
• Nahid P, Dorman SE, Alipanah N, et al. Official American Thoracic Society/Centers for disease control and prevention/infectious diseases Society of America clinical practice guidelines: treatment of drug-susceptible tuberculosis. Clin Infect Dis. 2016;63(7):e147–e195. doi:10.1093/cid/ciw37627516382
   PubMed Web of Science ®Google Scholar
• Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–1567. doi:10.1111/jam.1447831595643
   PubMed Web of Science ®Google Scholar
• Unissa AN, Subbian S, Hanna LE, Selvakumar N. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis. Infect Genet Evol. 2016;45:474–492. doi:10.1016/j.meegid.2016.09.00427612406
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China. N Engl J Med. 2012;366(23):2161–2170. doi:10.1056/NEJMoa110878922670902
   PubMed Web of Science ®Google Scholar
• He GX, Wang HY, Borgdorff MW, et al. Multidrug-resistant tuberculosis, People’s Republic of China, 2007–2009. Emerg Infect Dis. 2011;17(10):1831–1838. doi:10.3201/eid1710.11054622000352
   PubMed Web of Science ®Google Scholar
• Lawn SD. Advances in diagnostic assays for tuberculosis. Cold Spring Harb Perspect Med. 2015;5(12):a017806. doi:10.1101/cshperspect.a01780626253092
   PubMed Web of Science ®Google Scholar
• WHO. Technical Report on Critical Concentrations for Drug Susceptibility Testing of Medicines Used in the Treatment of Drug-Resistant Tuberculosis. Geneva: World Health Organization; 2018.
   Google Scholar
• Boehme CC, Nicol MP, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet. 2011;377(9776):1495–1505. doi:10.1016/S0140-6736(11)60438-821507477
   PubMed Web of Science ®Google Scholar
• Shah M, Chihota V, Coetzee G, Churchyard G, Dorman SE. Comparison of laboratory costs of rapid molecular tests and conventional diagnostics for detection of tuberculosis and drug-resistant tuberculosis in South Africa. BMC Infect Dis. 2013;13(1):352. doi:10.1186/1471-2334-13-35223895665
   PubMed Web of Science ®Google Scholar
• Miller BS, Gliddon HD, McKendry RA. Towards a future of rapid, low-cost, multiplexed detection of antimicrobial resistance markers for tuberculosis and other pathogens. Clin Chem. 2019;65(3):367–369. doi:10.1373/clinchem.2018.29671530626635
   PubMed Web of Science ®Google Scholar
• Saravanan M, Niguse S, Abdulkader M, et al. Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia. Microb Pathog. 2018;117:237–242. doi:10.1016/j.micpath.2018.02.04729486274
   PubMed Web of Science ®Google Scholar
• Zhou W, Sun J, Li X. Low-cost quantitative photothermal genetic detection of pathogens on a paper hybrid device using a thermometer. Anal Chem. 2020;92(21):14830–14837. doi:10.1021/acs.analchem.0c0370033059447
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhou Y, Wang C, et al. Rapid, accurate determination of multidrug resistance in M. tuberculosis isolates and sputum using a biochip system. Int J Tuberc Lung Dis. 2009;13(7):914–920.19555544
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li L, Luo F, et al. Rapid and accurate detection of RMP- and INH- resistant mycobacterium tuberculosis in spinal tuberculosis specimens by capitalBio DNA microarray: a prospective validation study. BMC Infect Dis. 2012;12(1):303. doi:10.1186/1471-2334-12-30323151186
   PubMed Web of Science ®Google Scholar
• Sun Y, Gao L, Xia H, et al. Accuracy of molecular diagnostic tests for drug-resistant tuberculosis detection in China: a systematic review. Int J Tuberc Lung Dis. 2019;23(8):931–942. doi:10.5588/ijtld.18.055031533884
   PubMed Web of Science ®Google Scholar
• Pang Y, Li Q, Ou X, et al. Cost-effectiveness comparison of Genechip and conventional drug susceptibility test for detecting multidrug-resistant tuberculosis in China. PLoS One. 2013;8(7):e69267. doi:10.1371/journal.pone.006926723935970
   PubMed Web of Science ®Google Scholar
• Zhu L, Jiang G, Wang S, et al. Biochip system for rapid and accurate identification of mycobacterial species from isolates and sputum. J Clin Microbiol. 2010;48(10):3654–3660. doi:10.1128/JCM.00158-1020686082
   PubMed Web of Science ®Google Scholar
• Strobl C, Malley J, Tutz G. An introduction to recursive partitioning: rationale, application, and characteristics of classification and regression trees, bagging, and random forests. Psychol Methods. 2009;14(4):323–348. doi:10.1037/a001697319968396
   PubMed Web of Science ®Google Scholar
• Vanbelle S. A new interpretation of the weighted kappa coefficients. Psychometrika. 2016;81(2):399–410. doi:10.1007/s11336-014-9439-425516203
   PubMed Web of Science ®Google Scholar
• Zhu L, Zuo LL, Zhou LT, et al. The analysis of drug-resistant gene mutations of mycobacterium tuberculosis by GeneChip in lianyungang, China. Clin Lab. 2020;66(01+02/2020):65–72. doi:10.7754/Clin.Lab.2019.190526
   Web of Science ®Google Scholar
• Pang Y, Xia H, Zhang Z, et al. Multicenter evaluation of genechip for detection of multidrug-resistant mycobacterium tuberculosis. J Clin Microbiol. 2013;51(6):1707–1713. doi:10.1128/JCM.03436-1223515537
   PubMed Web of Science ®Google Scholar
• Xu K, Wang S, Wu J, et al. Performance of biochip system in detecting drug resistant and multidrug-resistant tuberculosis using sputum collected from multiple clinical settings in Zhejiang, China. Sci Rep. 2018;8(1):10587. doi:10.1038/s41598-018-28955-030002508
   PubMed Web of Science ®Google Scholar
• Zhu L, Liu Q, Martinez L, et al. Diagnostic value of GeneChip for detection of resistant mycobacterium tuberculosis in patients with differing treatment histories. J Clin Microbiol. 2015;53(1):131–135. doi:10.1128/JCM.02283-1425355771
   PubMed Web of Science ®Google Scholar
• Wasihun AG, Dejene TA, Hailu GG. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern Ethiopia: a cross sectional study. PLoS One. 2020;15(11):e0240361. doi:10.1371/journal.pone.024036133147218
   PubMed Web of Science ®Google Scholar
• Almeida D, Rodrigues C, Udwadia ZF, et al. Incidence of multidrug-resistant tuberculosis in urban and rural India and implications for prevention. Clin Infect Dis. 2003;36(12):e152–154. doi:10.1086/37493112802779
   PubMed Web of Science ®Google Scholar
• Wang W, Wang J, Zhao Q, et al. Contribution of rural-to-urban migration in the prevalence of drug resistant tuberculosis in China. Eur J Clin Microbiol Infect Dis. 2011;30(4):581–586. doi:10.1007/s10096-010-1125-621174222
   PubMed Web of Science ®Google Scholar
• Pang Y, Ruan YZ, Zhao J, et al. Diagnostic dilemma: treatment outcomes of tuberculosis patients with inconsistent rifampicin susceptibility. Int J Tuberc Lung Dis. 2014;18(3):357–362. doi:10.5588/ijtld.13.045924670576
   PubMed Web of Science ®Google Scholar
• Cui ZL, Hu ZY, Wang J, Zhang YR, Chen HP, Weng XH. [Comparison of four methods in the detection of isoniazid resistance in clinical isolates of mycobacterium tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi. 2005;28(4):245–249. Chinese.15854434
   PubMedGoogle Scholar
• Van Deun A, Barrera L, Bastian I, et al. Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results. J Clin Microbiol. 2009;47(11):3501–3506. doi:10.1128/JCM.01209-0919759221
   PubMed Web of Science ®Google Scholar
• Traore H, Fissette K, Bastian I, Devleeschouwer M, Portaels F. Detection of rifampicin resistance in Mycobacterium tuberculosis isolates from diverse countries by a commercial line probe assay as an initial indicator of multidrug resistance. Int J Tuberc Lung Dis. 2000;4(5):481–484.10815743
   PubMed Web of Science ®Google Scholar
• WHO. Anti-Tuberculosis Drug Resistance in the World: Fourth Global Report./The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance, 2002–2007. Geneva: World Health Organization; 2008.
   Google Scholar
• Tornheim JA, Udwadia ZF, Gupta A, Shorter A. Regimen for rifampin-resistant tuberculosis. N Engl J Med. 2019;381(11):e22. doi:10.1056/NEJMc1905782
   Web of Science ®Google Scholar
• Weyer K, Mirzayev F, Migliori GB, et al. Rapid molecular TB diagnosis: evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J. 2013;42(1):252–271. doi:10.1183/09031936.0015721223180585
   PubMed Web of Science ®Google Scholar
• El-Hajj HH, Marras SA, Tyagi S, Kramer FR, Alland D. Detection of rifampin resistance in mycobacterium tuberculosis in a single tube with molecular beacons. J Clin Microbiol. 2001;39(11):4131–4137. doi:10.1128/JCM.39.11.4131-4137.200111682541
   PubMed Web of Science ®Google Scholar
• Rigouts L, Gumusboga M, de Rijk WB, et al. Rifampin resistance missed in automated liquid culture system for mycobacterium tuberculosis isolates with specific rpoB mutations. J Clin Microbiol. 2013;51(8):2641–2645. doi:10.1128/JCM.02741-1223761146
   PubMed Web of Science ®Google Scholar
• Van Deun A, Aung KJ, Bola V, et al. Rifampin drug resistance tests for tuberculosis: challenging the gold standard. J Clin Microbiol. 2013;51(8):2633–2640. doi:10.1128/JCM.00553-1323761144
   PubMed Web of Science ®Google Scholar